| Literature DB >> 34066875 |
Jiapeng Tang1,2, Xiwen Liu1,2, Yan Ge3,4, Fangfang Wang5.
Abstract
The main core of wound treatment is cell growth and anti-infection. To accelerate the proliferation of fibroblasts in the wound and prevent woundEntities:
Keywords: antibacterial activity; cell proliferation; kerateine anchoring; nanofibers; silver nanoparticles
Year: 2021 PMID: 34066875 PMCID: PMC8125921 DOI: 10.3390/molecules26092783
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Schematic illustration of in situ anchoring.
Figure 2Degradation behavior of the HHK/PEO/PVA nanofibers treated with different concentrations of the silver nitrate solution.
Figure 3HAADF image, EDS mapping and an analysis of the AgNP-HHK/PEO/PVA nanofibers.
Element analysis of the spectra from Area #1 (Figure 3).
| Element | Atomic Fraction (%) | Atomic Error (%) | Mass Fraction (%) | Mass Error (%) | Fit Error (%) |
|---|---|---|---|---|---|
| C | 90.02 | 3.38 | 79.01 | 1.88 | 0.49 |
| O | 8.17 | 1.67 | 9.55 | 1.93 | 1.73 |
| N | 0.38 | 0.21 | 0.39 | 0.22 | 51.31 |
| S | 0.04 | 0.01 | 0.09 | 0.02 | 4.08 |
| Ag | 1.39 | 0.17 | 10.95 | 1.28 | 0.13 |
Figure 4SEM micrographs and diameter distribution histograms of (a,a′) PEO/PVA nanofibrous mats, (b,b′) HHK/PEO/PVA nanofibrous mats and (c,c′) AgNP-HHK/PEO/PVA nanofibrous mats.
Figure 5FTIR spectra of the PEO/PVA, HHK/PEO/PVA and AgNP-HHK/PEO/PVA nanofibrous mats.
Figure 6X-ray diffraction patterns of the PEO/PVA, HHK/PEO/PVA and AgNP-HHK/PEO/PVA nanofibrous mats.
Figure 7(a) DSC curves and (b) TGA and TGA derivative curves of the PEO/PVA, HHK/PEO/PVA and AgNP-HHK/PEO/PVA nanofibrous mats.
DSC and TGA data of the (a) PEO/PVA, (b) HHK/PEO/PVA and (c) AgNP-HHK/PEO/PVA nanofibrous mats.
| Sample | DSC | TGA | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Δ | Δ | Δ | Δ | Peak1 | Peak2 | Peak3 | Residue at 600 °C/% | |||||
| a | 47.57 | −52.88 | 195.96 | −621.34 | 339.29 | −3256.72 | 439.06 | −303.48 | 199.70 | 335.00 | 417.72 | 7.31 |
| b | 44.93 | −29.68 | 167.25 | −491.06 | 346.11 | −2909.37 | 481.08 | −2153.35 | 174.84 | 336.32 | 479.54 | 9.01 |
| c | 39.87 | −44.34 | None | None | 343.45 | −2687.29 | 481.39 | −2421.50 | None | 329.39 | 482.18 | 10.52 |
Figure 8(a) Inhibition zones for neat PEO/PVA (1), HHK/PEO/PVA (2) and AgNP-HHK/PEO/PVA (3) nanofibrous mats against S. aureus, E. coli and C. albicans, and (b) the results analysis of the antibacterial test. *, p < 0.05; **, p < 0.01; n = 3.
Figure 9Cytotoxicity profile of the solution extracted from the (a) PEO/PVA, (b) HHK/PEO/PVA and (c) AgNP-HHK/PEO/PVA nanofibrous mats by the NIH3T3 cells. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001. ns, p > 0.05, which meant that there were no significant differences compared to the control; n = 6.